In August 2015 the Federal Economic Competition Commission (COFECE) approved a concentration between Dutch fund Moench Coöperatif, UA and one of the major pharmaceutical product distributors in Mexico, Marzam, through which the former acquired control over the latter. The concentration was approved without commitments, as the COFECE was advised that Moench Coöperatif did not participate in the same market as Marzam and thus that there was no overlap between the agents involved.